مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

70
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

57
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review

Pages

  248-259

Abstract

 Phosphodiesterase type 5 inhibitors such as sildenafil citrate and tadalafil are well known for the treatment of erectile dysfunction. However, their use in the presence of pulmonary hypertension can cause ophthalmologic side effects, including non-arteritic optic ischemic neuropathy, chorioretinopathy, glaucoma, and optic atrophy. The present review aimed to identify these visual side effects and provide recommendations. We identified articles published from January 2000 to March 2019 on diseases arising from the management of sexual dysfunction in urology or pulmonary hypertension in pneumonia that could cause pathologic alterations in eye structure based on a literature search of the MEDLINE electronic database using keywords for the most common adverse effects and different kinds of phosphodiesterase 5 inhibitors. After applying the exclusion criteria, we selected 36 of the 77 articles initially identified to write the narrative review and added 20 additional articles to completely describe the pathological entities. Phosphodiesterase type 5 inhibitors can cause side effects in the eye including ocular surface abnormalities, increased intraocular pressure and glaucoma, uveitis, non-arteritic ischemic neuropathy, chorioretinopathy, retinal occlusion, and visual field changes. There is an increased need for well-performed studies to better understand these side effects, which are common due to the wide use of sildenafil.

Multimedia

  • No record.

    • Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    Barroso, Francisco, Ribeiro, Joao Crispim, & Miranda, Eduardo P.. (2021). Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review. JOURNAL OF OPHTHALMIC AND VISION RESEARCH, 16(2), 248-259. SID. https://sid.ir/paper/983835/en

    Vancouver: Copy

    Barroso Francisco, Ribeiro Joao Crispim, Miranda Eduardo P.. Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review. JOURNAL OF OPHTHALMIC AND VISION RESEARCH[Internet]. 2021;16(2):248-259. Available from: https://sid.ir/paper/983835/en

    IEEE: Copy

    Francisco Barroso, Joao Crispim Ribeiro, and Eduardo P. Miranda, “Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review,” JOURNAL OF OPHTHALMIC AND VISION RESEARCH, vol. 16, no. 2, pp. 248–259, 2021, [Online]. Available: https://sid.ir/paper/983835/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button